Summary
Intuitive Surgical, Inc. (ISRG) reported strong performance for the fiscal year ended December 31, 2009. Total revenue reached $1,052 million, a 20% increase year-over-year, driven by a 51% surge in surgical procedures performed using their da Vinci Surgical Systems. This growth was fueled by expanding adoption in key specialties like urology and gynecology, with prostatectomies and hysterectomies being major contributors. The company also saw robust growth in recurring revenue from instruments and accessories, which constituted 53% of total revenue, indicating increasing utilization of their installed base. The company successfully launched its new da Vinci Si Surgical System in Q2 2009, featuring enhanced imaging, an improved user interface, and a dual console for training and collaborative surgery, which is expected to drive future growth. Despite a challenging economic environment in 2009, ISRG demonstrated resilience, with system sales remaining stable and recurring revenue growing significantly. The company ended the year with a strong cash position of $1,172 million, underscoring its financial health and ability to fund ongoing operations and future expansion.
Financial Highlights
46 data points| Revenue | $1.05B |
| Cost of Revenue | $301.10M |
| Gross Profit | $751.10M |
| R&D Expenses | $95.10M |
| SG&A Expenses | $278.60M |
| Operating Expenses | $373.70M |
| Operating Income | $377.40M |
| Net Income | $232.60M |
| EPS (Basic) | $0.67 |
| EPS (Diluted) | $0.66 |
| Shares Outstanding (Basic) | 344.70M |
| Shares Outstanding (Diluted) | 352.80M |
Key Highlights
- 1Total revenue increased by 20% to $1,052 million in 2009.
- 2Surgical procedures performed using da Vinci systems grew by 51% to approximately 205,000.
- 3Recurring revenue (instruments, accessories, services) grew by 34% to $562 million, representing 53% of total revenue.
- 4Launched the new da Vinci Si Surgical System in Q2 2009, enhancing visual acuity, ease of use, and introducing a dual console.
- 5Sold 338 da Vinci Surgical Systems, a slight increase from 335 in 2008.
- 6Maintained a strong installed base of 1,395 da Vinci Surgical Systems.
- 7Ended the year with $1,172 million in cash, cash equivalents, and investments, demonstrating strong liquidity.